Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 10

1.

Translocator protein (TSPO) ligand-Ara-C (cytarabine) conjugates as a strategy to deliver antineoplastic drugs and to enhance drug clinical potential.

Denora N, Laquintana V, Trapani A, Lopedota A, Latrofa A, Gallo JM, Trapani G.

Mol Pharm. 2010 Dec 6;7(6):2255-69. doi: 10.1021/mp100235w. Epub 2010 Nov 8.

PMID:
20958082
2.

Targeted cancer therapy: conferring specificity to cytotoxic drugs.

Chari RV.

Acc Chem Res. 2008 Jan;41(1):98-107. Epub 2007 Aug 18. Review.

PMID:
17705444
3.

Lipid nucleoside conjugates for the treatment of cancer.

Alexander RL, Kucera GL.

Curr Pharm Des. 2005;11(9):1079-89. Review.

PMID:
15853657
4.

Cytotoxic chemotherapy: advances in delivery, pharmacology, and testing.

Ciordia R, Supko J, Gatineau M, Batchelor T.

Curr Oncol Rep. 2000 Sep;2(5):445-53. Review.

PMID:
11122877
5.

Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma.

Zhang F, Xu CL, Liu CM.

Drug Des Devel Ther. 2015 Apr 9;9:2089-100. doi: 10.2147/DDDT.S79592. eCollection 2015. Review.

6.

The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy.

Roger M, Clavreul A, Venier-Julienne MC, Passirani C, Montero-Menei C, Menei P.

Biomaterials. 2011 Mar;32(8):2106-16. doi: 10.1016/j.biomaterials.2010.11.056. Epub 2010 Dec 22. Review.

PMID:
21183214
7.

Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas.

Weaver M, Laske DW.

J Neurooncol. 2003 Oct;65(1):3-13. Review.

PMID:
14649881
8.

Could nanoparticle systems have a role in the treatment of cerebral gliomas?

Caruso G, Caffo M, Alafaci C, Raudino G, Cafarella D, Lucerna S, Salpietro FM, Tomasello F.

Nanomedicine. 2011 Dec;7(6):744-52. doi: 10.1016/j.nano.2011.02.008. Epub 2011 Mar 17. Review.

PMID:
21419873
9.

Principles in the design of ligand-targeted cancer therapeutics and imaging agents.

Srinivasarao M, Galliford CV, Low PS.

Nat Rev Drug Discov. 2015 Mar;14(3):203-19. doi: 10.1038/nrd4519. Epub 2015 Feb 20. Review.

PMID:
25698644
10.

Insights into the molecular mechanisms of action of bioportides: a strategy to target protein-protein interactions.

Howl J, Jones S.

Expert Rev Mol Med. 2015 Jan 27;17:e1. doi: 10.1017/erm.2014.24. Review.

PMID:
26258595
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk